Novo Nordisk AS is lowering prices of its top-selling WeGovy weight-loss drug in China, as the Danish drugmaker braces for intense competition from local rivals next year when the patent for its blockbuster treatment ends. Novo Nordisk slashed WeGovy prices by up to 37% in India last month. (Reuters) The company did not give details […]
